Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

829.76
-39.8200-4.58%
Post-market: 823.80-5.9600-0.72%19:21 EDT
Volume:5.96M
Turnover:5.00B
Market Cap:786.75B
PE:70.86
High:863.19
Open:853.91
Low:825.78
Close:869.58
Loading ...

Why Eli Lilly and Company (LLY) is the Best Long-Term Growth Stock to Buy Now

Insider Monkey
·
12 Feb

Why the 'best hedge' against the AI rally losing steam in 2025 is healthcare: Morning Brief

Yahoo Finance
·
12 Feb

Health Rounds: Hormone delivery via skin patch may ease prostate cancer treatment side effects

Reuters
·
12 Feb

Eli Lilly and Company (LLY): A Bull Case Theory

Insider Monkey
·
12 Feb

Robert Bruce's Strategic Moves: AerCap Holdings NV Takes Center Stage with 2.16% Portfolio Impact

GuruFocus.com
·
12 Feb

Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma?

Insider Monkey
·
12 Feb

Eli Lilly & Co (LLY) Gets a Buy from Truist Financial

TIPRANKS
·
11 Feb

Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY), Recursion Pharmaceuticals (RXRX) and Labcorp Holdings (LH)

TIPRANKS
·
11 Feb

Eli Lilly (LLY) Expands AdvanCell Partnership for Cutting-Edge Cancer Therapies

Insider Monkey
·
11 Feb

BRIEF-Eli Lilly Files For Six-Part Notes Offering Of Up To $6.50 Billion- SEC Filing

Reuters
·
11 Feb

Eli Lilly Files for Six-Part Notes Offering of up to $6.50 Bln- SEC Filing

THOMSON REUTERS
·
11 Feb

PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co

GuruFocus.com
·
11 Feb

Eli Lilly & Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Feb

Eli Lilly and Company (LLY): The Best Dividend Growth Stock With Over 10% Yearly Increases?

Insider Monkey
·
11 Feb

Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals

Benzinga
·
11 Feb

INCY's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales

Zacks
·
10 Feb